Viking Therapeutics (VKTX) Tops Q3 EPS by 1c

Viking Therapeutics (NASDAQ: VKTX) reported Q3 EPS of ($0.20), $0.01 better than the analyst estimate of ($0.21).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• ICICI Securities Resumes Dalmia Bharat Ltd (DALBHARA:IN) at Add (2)
• UBS Upgrades Apollo Tyres (APTY:IN) to Buy